AEON vs AOS · P/E 0.0, $8.6M cap vs P/E 19, rev $1.00B
AEON Biopharma, Inc. (AEON) versus Smith AO Corporation (AOS) — a side-by-side from cached financials, not a winner call.
AEON Biopharma, Inc. (AEON) is a biotechnology company listed on US.
Smith AO Corporation (AOS) is a specialty industrial machinery company listed on US.
AEON does not have a complete income-statement cache yet.
Latest reported AOS revenue for 2026-06-30 was $1.00B. Net income was $124.9M. Revenue was up 6.2% from 2026-03-31 to 2026-06-30. AOS currently screens at market cap $9.73B and trailing P/E 19.1.
AEON currently screens at market cap $8.6M and trailing P/E 0.0. AOS currently screens at market cap $9.73B and trailing P/E 19.1.
Not investment advice. Open the AEON and AOS stock pages for the full models.
Not investment advice.